These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36413079)

  • 1. Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis.
    Campochiaro C; Hoffmann-Vold AM; Avouac J; Henes J; de Vries-Bouwstra J; Smith V; Siegert E; Airò P; Oksel F; Pellerito R; Vanthuyne M; Pozzi MR; Inanc M; Sibilia J; Gabrielli A; Distler O; Allanore Y;
    Rheumatology (Oxford); 2023 Jul; 62(7):2483-2491. PubMed ID: 36413079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database.
    Hoffmann-Vold AM; Allanore Y; Alves M; Brunborg C; Airó P; Ananieva LP; Czirják L; Guiducci S; Hachulla E; Li M; Mihai C; Riemekasten G; Sfikakis PP; Kowal-Bielecka O; Riccardi A; Distler O;
    Ann Rheum Dis; 2021 Feb; 80(2):219-227. PubMed ID: 32988845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial lung disease in South Africans with systemic sclerosis.
    Ashmore P; Tikly M; Wong M; Ickinger C
    Rheumatol Int; 2018 Apr; 38(4):657-662. PubMed ID: 29185086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.
    Chartrand S; Lee JS; Swigris JJ; Stanchev L; Fischer A
    Lung; 2019 Dec; 197(6):709-713. PubMed ID: 31583453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
    Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
    Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
    Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
    Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Ro/SS-A antibody is associated with worse pulmonary outcome and reduced overall survival in systemic sclerosis.
    Meridor K; Sagy I; Molad Y
    Mod Rheumatol; 2022 Oct; 32(6):1086-1093. PubMed ID: 34927207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Systemic Sclerosis-associated Interstitial Lung Disease Burn Out? Specific Phenotypes of Disease Progression.
    Guler SA; Winstone TA; Murphy D; Hague C; Soon J; Sulaiman N; Li KH; Dunne J; Wilcox PG; Ryerson CJ
    Ann Am Thorac Soc; 2018 Dec; 15(12):1427-1433. PubMed ID: 30188737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
    Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL
    Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study.
    Wangkaew S; Euathrongchit J; Wattanawittawas P; Kasitanon N; Louthrenoo W
    Mod Rheumatol; 2016 Jul; 26(4):588-93. PubMed ID: 26561397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis.
    Guler S; Sarbu AC; Stalder O; Allanore Y; Bernardino V; Distler J; Gabrielli A; Hoffmann-Vold AM; Matucci-Cerinic M; Müller-Ladner U; Ortiz-Santamaria V; Rednic S; Riccieri V; Smith V; Ullman S; Walker UA; Geiser TK; Distler O; Maurer B; Kollert F
    Thorax; 2023 Dec; 78(12):1188-1196. PubMed ID: 37798114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China.
    Hu S; Hou Y; Wang Q; Li M; Xu D; Zeng X
    Arthritis Res Ther; 2018 Oct; 20(1):235. PubMed ID: 30348207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis.
    Hoa S; Bernatsky S; Steele RJ; Baron M; Hudson M;
    Rheumatology (Oxford); 2020 May; 59(5):1108-1117. PubMed ID: 31535689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors of systemic sclerosis-associated interstitial lung disease in East Asia: A systematic review and meta-analysis.
    Qiu M; Nian X; Pang L; Yu P; Zou S
    Int J Rheum Dis; 2021 Dec; 24(12):1449-1459. PubMed ID: 34418313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts.
    Liem SIE; Boonstra M; le Cessie S; Riccardi A; Airo P; Distler O; Matucci-Cerinic M; Caimmi C; Siegert E; Allanore Y; Huizinga TWJ; Toes REM; Scherer HU; de Vries-Bouwstra JK;
    Lancet Rheumatol; 2022 Oct; 4(10):e699-e709. PubMed ID: 38265968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, prevalence and regional distribution of systemic sclerosis and related interstitial lung Disease: A nationwide retrospective cohort study.
    Knarborg M; Hyldgaard C; Bendstrup E; Davidsen JR; Løkke A; Shaker SB; Hilberg O
    Chron Respir Dis; 2022; 19():14799731221125559. PubMed ID: 36123773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis.
    Tomiyama F; Watanabe R; Ishii T; Kamogawa Y; Fujita Y; Shirota Y; Sugimura K; Fujii H; Harigae H
    Tohoku J Exp Med; 2016 Aug; 239(4):297-305. PubMed ID: 27487743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of male sex on survival in systemic sclerosis.
    Hussein H; Lee P; Chau C; Johnson SR
    J Rheumatol; 2014 Nov; 41(11):2193-200. PubMed ID: 25274896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.
    Fairley JL; Hansen D; Ross L; Proudman S; Sahhar J; Ngian GS; Walker J; Host LV; Morrisroe K; Apostolopoulous D; Ferdowsi N; Wilson M; Tabesh M; Stevens W; Nikpour M;
    Arthritis Res Ther; 2023 May; 25(1):77. PubMed ID: 37173780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.